Fairvalue-Calculator Fairvalue-Calculator
EN DE

Gwo Xi Stem Cell Applied Technology Co (6704) Fair Value & Analysis

Healthcare · TW · Market cap 2.0B TWD

Price21.80 TWD
Fair Value18.15 TWD
Upside-16.7%
Quality95/100
Evidence: Low Range 13.61 TWD – 22.68 TWD

Fair value as of: Jun 24, 2026

Analysis

Gwo Xi Stem Cell Applied Technology Co (6704) currently trades at 21.80 TWD, while our model-based Fair Value estimate is 18.15 TWD — implying the stock looks roughly 16.7% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Gwo Xi Stem Cell Applied Technology Co. , Ltd develops stem cell technology for patients with unmet medical needs. Its products under development include GXHPC1, an autologous adipose-derived stem cell therapy in phase II clinical trials for use in the treatment of liver cirrhosis; and GXNPC1, an autologous adipose-derived stem cell therapy in phase II clinical trials for use in the treatment of chronic stroke. The company is also developing GXCPC1, an allogeneic adipose-derived stem cells therapy in phase I/II clinical trials for use in the treatment of osteoarthritis; and GXIPC1, an allogeneic adipose-derived stem cells therapy in phase I clinical trials for use in the treatment of diabetes. The company was founded in 2011 and is based in Zhubei, Taiwan.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is Gwo Xi Stem Cell Applied Technology Co (6704) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 18.15 TWD versus a price of 21.80 TWD — about −17% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 6704?
Our 21-model fair value for Gwo Xi Stem Cell Applied Technology Co is 18.15 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 21.80 TWD.
What is the quality score of 6704?
Gwo Xi Stem Cell Applied Technology Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.